NPC 16377

Drug Profile

NPC 16377

Alternative Names: NPC 16316

Latest Information Update: 27 Jun 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Scios
  • Class Antipsychotics; Flavonoids; Piperidines
  • Mechanism of Action Opioid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Neurological disorders; Psychotic disorders

Most Recent Events

  • 27 Jun 2001 No-Development-Reported for Neurological disorders in USA (Unknown route)
  • 27 Jun 2001 No-Development-Reported for Psychotic disorders in USA (Unknown route)
  • 07 Feb 1997 Preclinical development for Neurological disorders in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top